首页 > 最新文献

Epidemiologie Mikrobiologie Imunologie最新文献

英文 中文
COVID-19 reinfections. COVID-19再感染。
IF 0.5 4区 医学 Q4 Medicine Pub Date : 2021-01-01
K Fabiánová, J Kynčl, I Vlčková, H Jiřincová, J Košťálová, M Liptáková, H Orlíková, H Šebestová, R Limberková, B Macková, M Malý

Reports of SARS-CoV-2 reinfections are on the rise. This study focused on reinfections in patients with confirmed COVID-19 in the Czech Republic. Between 1 March 2020 and 9 November 2020, 362 084 cases with the onset of symptoms before 31 October 2020 were reported. Overall, 28 cases of symptomatic SARS-CoV-2 reinfections were identified, 11 in males and 17 in females, age range 25-80 years, median age 46 years. The interval between the first and second episodes of the disease ranged from 101 to 231 days, and the median interval was 201.5 days. During both symptomatic episodes, all patients have been tested by RT-PCR. Altogether 26 patients (92.9%) have been tested negative after recovery from the first episode of COVID-19. Symptomatic reinfections occurred in nearly 0.2% of all patients at risk. Most patients with reinfection had mild symptoms in both episodes, and only three episodes were moderate to severe. Thus, reinfections may have been underdiagnosed. In summary, COVID-19 reinfections are possible and not exceptional.

SARS-CoV-2再感染的报告正在上升。这项研究的重点是捷克共和国确诊的COVID-19患者的再感染。2020年3月1日至11月9日期间,报告了在2020年10月31日之前出现症状的362 084例病例。总共发现28例有症状的SARS-CoV-2再感染病例,男性11例,女性17例,年龄25-80岁,中位年龄46岁。第一次和第二次发病之间的时间间隔为101 ~ 231天,中位时间间隔为201.5天。在两次症状发作期间,所有患者都进行了RT-PCR检测。新冠肺炎首发痊愈后检测阴性26例(92.9%)。有症状的再感染发生在近0.2%的高危患者中。大多数再感染患者在两次发作中都有轻微症状,只有三次发作为中度至重度。因此,再感染可能未被充分诊断。总之,COVID-19再感染是可能的,而且并不罕见。
{"title":"COVID-19 reinfections.","authors":"K Fabiánová,&nbsp;J Kynčl,&nbsp;I Vlčková,&nbsp;H Jiřincová,&nbsp;J Košťálová,&nbsp;M Liptáková,&nbsp;H Orlíková,&nbsp;H Šebestová,&nbsp;R Limberková,&nbsp;B Macková,&nbsp;M Malý","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Reports of SARS-CoV-2 reinfections are on the rise. This study focused on reinfections in patients with confirmed COVID-19 in the Czech Republic. Between 1 March 2020 and 9 November 2020, 362 084 cases with the onset of symptoms before 31 October 2020 were reported. Overall, 28 cases of symptomatic SARS-CoV-2 reinfections were identified, 11 in males and 17 in females, age range 25-80 years, median age 46 years. The interval between the first and second episodes of the disease ranged from 101 to 231 days, and the median interval was 201.5 days. During both symptomatic episodes, all patients have been tested by RT-PCR. Altogether 26 patients (92.9%) have been tested negative after recovery from the first episode of COVID-19. Symptomatic reinfections occurred in nearly 0.2% of all patients at risk. Most patients with reinfection had mild symptoms in both episodes, and only three episodes were moderate to severe. Thus, reinfections may have been underdiagnosed. In summary, COVID-19 reinfections are possible and not exceptional.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"70 1","pages":"62-67"},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25588782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The first laboratory confirmed invasive meningococcal disease of serogroup C with abdominal clinical presentation in Slovakia, 2019. 2019年斯洛伐克首例实验室确诊的伴有腹部临床表现的血清C群侵袭性脑膜炎球菌病。
IF 0.5 4区 医学 Q4 Medicine Pub Date : 2021-01-01
A Kružlíková, J Gőczeová, K Šoltys, R Piťková, B Ťažký, J Mikas

Acute abdominal clinical presentations as initial manifestation of meningococcal infection are uncommon and frequently provoked by hyperinvasive isolates of meningococci. 10% of patients infected by the meningococcal strain, that is on the rise in Europe, suffer from abdominal pain. We hereby report the first laboratory confirmed fatal case of an otherwise healthy adult male presented with acute abdominal pain during first 24-48 hours, masking Neisseria meningitidis (N. meningitidis) infection. In the National Reference Center for meningococci, in the blood of a man post-mortem, we identified N. meningitidis serogroup C using real time polymerase chain reaction (PCR). Subsequently, massivelly-parallel sequencing (MPS) was performed on isolated total DNA for pathogen confirmation and further investigation.

急性腹部临床表现作为脑膜炎球菌感染的初始表现是不常见的,经常由脑膜炎球菌的高侵袭性分离引起。在欧洲,感染脑膜炎球菌的患者中有10%患有腹痛。我们在此报告首例实验室确诊的死亡病例,一名健康的成年男性在最初的24-48小时内出现急性腹痛,掩盖了脑膜炎奈瑟菌(奈瑟菌)感染。在国家脑膜炎球菌参考中心,在一名男子死后的血液中,我们使用实时聚合酶链反应(PCR)鉴定出脑膜炎奈瑟菌血清C组。随后,对分离的总DNA进行大规模平行测序(MPS),以确认病原体并进一步调查。
{"title":"The first laboratory confirmed invasive meningococcal disease of serogroup C with abdominal clinical presentation in Slovakia, 2019.","authors":"A Kružlíková,&nbsp;J Gőczeová,&nbsp;K Šoltys,&nbsp;R Piťková,&nbsp;B Ťažký,&nbsp;J Mikas","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Acute abdominal clinical presentations as initial manifestation of meningococcal infection are uncommon and frequently provoked by hyperinvasive isolates of meningococci. 10% of patients infected by the meningococcal strain, that is on the rise in Europe, suffer from abdominal pain. We hereby report the first laboratory confirmed fatal case of an otherwise healthy adult male presented with acute abdominal pain during first 24-48 hours, masking Neisseria meningitidis (N. meningitidis) infection. In the National Reference Center for meningococci, in the blood of a man post-mortem, we identified N. meningitidis serogroup C using real time polymerase chain reaction (PCR). Subsequently, massivelly-parallel sequencing (MPS) was performed on isolated total DNA for pathogen confirmation and further investigation.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"70 1","pages":"72-75"},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25588784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The sensitivity of SARS-CoV-2 antigen tests in the view of large-scale testing. 基于大规模检测的SARS-CoV-2抗原检测敏感性分析
IF 0.5 4区 医学 Q4 Medicine Pub Date : 2021-01-01
P Dřevínek, J Hurych, Z Kepka, A Briksi, M Kulich, M Zajac, P Hubáček

Objectives: Antigen tests have emerged as an alternative to SARS-CoV-2 diagnostic PCR, thought to be valuable especially for the screening of bigger communities. To check appropriateness of the antigen based testing, we determined sensitivity of two point-of-care antigen tests when applied to a cohort of COVID-19 symptomatic, COVID-19 asymptomatic and healthy persons.

Methods: We examined nasopharyngeal swabs with antigen test 1 (Panbio Covid-19 Ag Rapid Test, Abbott) and antigen test 2 (Standard F Covid-19 Ag FIA, SD Biosensor). An additional nasopharyngeal and oropharyngeal swab of the same individual was checked with PCR (Allplex SARS-nCoV-2, Seegene). Within a 4-day period in October 2020, we collected specimens from 591 subjects. Of them, 290 had COVID-19 associated symptoms.

Results: While PCR positivity was detected in 223 cases, antigen test 1 and antigen test 2 were found positive in 148 (sensitivity 0.664, 95%CI 0.599, 0.722) and 141 (sensitivity 0.623, 95%CI 0.558, 0.684) patients, respectively. When only symptomatic patients were analysed, sensitivity increased to 0.738 (95%CI 0.667, 0.799) for the antigen test 1 and to 0.685 (95%CI 0.611, 0.750) for the antigen test 2. The substantial drop in sensitivity to 12.9% (95%CI 0.067, 0.234) was observed for samples with the PCR threshold cycle above > 30.

Conclusions: Low sensitivity of antigen tests leads to the considerable risk of false negativity. It is advisable to implement repeated testing with high enough frequency if the antigen test is used as a frontline screening tool, and to follow with PCR if it is applied to vulnerable populations.

目的:抗原检测已成为SARS-CoV-2诊断PCR的替代方法,被认为对较大社区的筛查尤其有价值。为了检查基于抗原检测的适宜性,我们测定了两种即时护理抗原检测在COVID-19症状、COVID-19无症状和健康人群中的敏感性。方法:采用抗原试验1 (Panbio Covid-19 Ag Rapid test, Abbott)和抗原试验2 (Standard F -19 Ag FIA, SD Biosensor)对鼻咽拭子进行检测。对同一个体的另一份鼻咽和口咽拭子进行PCR检查(Allplex SARS-nCoV-2, Seegene)。在2020年10月的4天内,我们收集了591名受试者的标本。其中290人有COVID-19相关症状。结果:223例检测到PCR阳性,其中抗原1和抗原2分别有148例(敏感性0.664,95%CI 0.599, 0.722)和141例(敏感性0.623,95%CI 0.558, 0.684)检测到阳性。当仅分析有症状的患者时,抗原试验1的敏感性增加到0.738 (95%CI 0.667, 0.799),抗原试验2的敏感性增加到0.685 (95%CI 0.611, 0.750)。对于PCR阈值周期高于>的样品,灵敏度大幅下降至12.9% (95%CI 0.067, 0.234);30.结论:抗原检测的低敏感性导致假阴性的风险较大。如果抗原检测被用作一线筛查工具,建议以足够高的频率进行重复检测,如果将其应用于易感人群,建议随后进行PCR检测。
{"title":"The sensitivity of SARS-CoV-2 antigen tests in the view of large-scale testing.","authors":"P Dřevínek,&nbsp;J Hurych,&nbsp;Z Kepka,&nbsp;A Briksi,&nbsp;M Kulich,&nbsp;M Zajac,&nbsp;P Hubáček","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>Antigen tests have emerged as an alternative to SARS-CoV-2 diagnostic PCR, thought to be valuable especially for the screening of bigger communities. To check appropriateness of the antigen based testing, we determined sensitivity of two point-of-care antigen tests when applied to a cohort of COVID-19 symptomatic, COVID-19 asymptomatic and healthy persons.</p><p><strong>Methods: </strong>We examined nasopharyngeal swabs with antigen test 1 (Panbio Covid-19 Ag Rapid Test, Abbott) and antigen test 2 (Standard F Covid-19 Ag FIA, SD Biosensor). An additional nasopharyngeal and oropharyngeal swab of the same individual was checked with PCR (Allplex SARS-nCoV-2, Seegene). Within a 4-day period in October 2020, we collected specimens from 591 subjects. Of them, 290 had COVID-19 associated symptoms.</p><p><strong>Results: </strong>While PCR positivity was detected in 223 cases, antigen test 1 and antigen test 2 were found positive in 148 (sensitivity 0.664, 95%CI 0.599, 0.722) and 141 (sensitivity 0.623, 95%CI 0.558, 0.684) patients, respectively. When only symptomatic patients were analysed, sensitivity increased to 0.738 (95%CI 0.667, 0.799) for the antigen test 1 and to 0.685 (95%CI 0.611, 0.750) for the antigen test 2. The substantial drop in sensitivity to 12.9% (95%CI 0.067, 0.234) was observed for samples with the PCR threshold cycle above &gt; 30.</p><p><strong>Conclusions: </strong>Low sensitivity of antigen tests leads to the considerable risk of false negativity. It is advisable to implement repeated testing with high enough frequency if the antigen test is used as a frontline screening tool, and to follow with PCR if it is applied to vulnerable populations.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"70 3","pages":"156-160"},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39514539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Questionnaire-based epidemiological analysis of acute gastroenteritis outbreak among employees of two neighbouring institutions sharing canteen in Prague 2019. 2019年布拉格相邻两所共用食堂员工急性肠胃炎暴发的问卷流行病学分析
IF 0.5 4区 医学 Q4 Medicine Pub Date : 2021-01-01
M Liptáková, M Špačková, S Balasegaram, H Orlíková, J Kynčl

Objectives: On 17th Dec 2019 gastroenteritis outbreak occurred in two Pragues neighbouring institutions. Investigation aimed to describe outbreak, identify etiological agent, vehicle and propose control measures.

Methods: Routine outbreak investigation and retrospective cohort study was done. Data collected via online questionnaire were analysed using descriptive, univariate and stratified analysis.

Results: Of 960 employees, 276 responded (29%). We identified 39 (14%) cases, one tested norovirus positive. Canteen staff didnt report illness. No food item or environmental sample was tested. Sichuan pork served for lunch on 17th Dec was the most likely vehicle of outbreak (odds ratio (OR) 5.02, 95% confidence interval (CI) 1.98-12.64). Eating Sichuan pork and Chinese soup showed OR 31.5, 95% CI 5.0-320.7. Twenty-two (56%) cases can be explained by consumption of these food items.

Conclusions: Epidemiological analytical method provided evidence of likely vehicle. We did not find the source. Control measures were early ensured and outbreak ceased. We emphasise full outbreak investigation using analytical epidemiology, environmental screening and microbiological testing of cases and possibly all kitchen staff.

目的:2019年12月17日,在布拉格的两个邻近机构发生了肠胃炎疫情。调查的目的是描述疫情,确定病原、传播媒介,提出控制措施。方法:开展常规疫情调查和回顾性队列研究。通过在线问卷收集的数据采用描述性、单变量和分层分析进行分析。结果:在960名员工中,276人(29%)做出了回应。我们发现39例(14%)病例,1例诺如病毒检测呈阳性。食堂员工没有报告生病。没有测试食品或环境样本。12月17日午餐食用的四川猪肉是最可能的暴发媒介(优势比(OR) 5.02, 95%可信区间(CI) 1.98 ~ 12.64)。食用四川猪肉和中国汤显示OR为31.5,95% CI为5.0-320.7。22例(56%)病例可以通过食用这些食品来解释。结论:流行病学分析方法为可能的媒介提供了证据。我们没有找到源头。及早采取控制措施,疫情得到遏制。我们强调通过分析流行病学、环境筛查和微生物测试对病例和可能的所有厨房工作人员进行全面的疫情调查。
{"title":"Questionnaire-based epidemiological analysis of acute gastroenteritis outbreak among employees of two neighbouring institutions sharing canteen in Prague 2019.","authors":"M Liptáková,&nbsp;M Špačková,&nbsp;S Balasegaram,&nbsp;H Orlíková,&nbsp;J Kynčl","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>On 17th Dec 2019 gastroenteritis outbreak occurred in two Pragues neighbouring institutions. Investigation aimed to describe outbreak, identify etiological agent, vehicle and propose control measures.</p><p><strong>Methods: </strong>Routine outbreak investigation and retrospective cohort study was done. Data collected via online questionnaire were analysed using descriptive, univariate and stratified analysis.</p><p><strong>Results: </strong>Of 960 employees, 276 responded (29%). We identified 39 (14%) cases, one tested norovirus positive. Canteen staff didnt report illness. No food item or environmental sample was tested. Sichuan pork served for lunch on 17th Dec was the most likely vehicle of outbreak (odds ratio (OR) 5.02, 95% confidence interval (CI) 1.98-12.64). Eating Sichuan pork and Chinese soup showed OR 31.5, 95% CI 5.0-320.7. Twenty-two (56%) cases can be explained by consumption of these food items.</p><p><strong>Conclusions: </strong>Epidemiological analytical method provided evidence of likely vehicle. We did not find the source. Control measures were early ensured and outbreak ceased. We emphasise full outbreak investigation using analytical epidemiology, environmental screening and microbiological testing of cases and possibly all kitchen staff.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"70 2","pages":"91-97"},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39328098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genotyping of noroviruses from patients of the Pilsen University Hospital in the Czech Republic, 2017-2020. 2017-2020年捷克皮尔森大学医院患者诺如病毒基因分型分析
IF 0.5 4区 医学 Q4 Medicine Pub Date : 2021-01-01
P Pazdiora, P Vašíčková, M Krzyžánková

Objective: Noroviruses are members of the Caliciviridae family and are currently segregated into at least 10 genogroups. The distribution of these viruses in the Czech Republic has not yet been investigated in detail. A pilot study was performed to contribute to the overall knowledge and understanding of norovirus circulation in the population. Clinical specimens from patients diagnosed with norovirus infection during their hospitalization at the Pilsen University Hospital were genotyped.

Material and methods: A total of 118 patients were diagnosed with norovirus infection between July 2017 and March 2020. Stool samples from patients presenting with gastroenteritis were routinely screened by the RIDA®QUICK Norovirus Test (R-Biopharm AG), a rapid chromatographic immunoassay for the qualitative detection of Norovirus genogroups I and II, according to the manufacturers instructions. Norovirus positive samples were subsequently analysed by molecular biological methods. Stool suspensions (10%) were prepared with phosphate-buffered saline, and nucleic acid was extracted using the QIAamp Viral RNA kit (Qiagen) according to the manufacturers instructions. To investigate the genotype distribution, RT-PCR targeting specific sections of the norovirus genome (region C) was employed, followed by purification of PCR products using the QIAquick PCR Purification Kit (Qiagen) and sequencing (Eurofins Genomics). The sequences obtained were analysed by the MEGA X software, and the results of phylogenetic analyses were confirmed by Norovirus Typing Tool Version 2.0 (https://www.rivm.nl/mpf/typingtool/ norovirus/.

Results: During the study period, 14 norovirus genotypes or genogroup variants NoV GI, NoV GII and NoV GIX (previously NoV GII.15) were identified. The major genotype NoV GII.4 Sydney-2012 accounted for a total of 70.3% of norovirus gastroenteritis cases. This norovirus variant was detected in 24 months out of 34 months of the study period. In general, the number of norovirus infections increased during autumn and winter months (October to March) when 68 (57.6%) cases were diagnosed. Although norovirus infection was confirmed in all age categories (age range 0-96 years, median 8, mean 27.9), the statistical analysis revealed a significant difference in the incidence of NoV GII.4 infection between the age group 0-4 years and older patients (χ2 = 3.95, P = 0.047). Many patients (51) were residents of the Pilsen-city district. The case history data showed that 35 of them (29.7%) had another family member who developed symptoms of gastroenteritis at the time of the onset of their infection.

Conclusion: The pilot study is the first attempt to map the molecular epidemiology of noroviruses, not only in the Pilsen Region but also in the whole Czech Republic. Despite the relatively low number of officially reported cases, noroviruses are undoubtedly one of the most importan

目的:诺如病毒是冠状病毒科的成员,目前被划分为至少10个基因群。这些病毒在捷克共和国的分布尚未得到详细调查。进行了一项初步研究,以促进对诺如病毒在人群中的传播的总体认识和理解。对在皮尔森大学医院住院期间诊断为诺如病毒感染的患者的临床标本进行基因分型。材料与方法:2017年7月至2020年3月诊断为诺如病毒感染的患者118例。根据生产商说明,采用RIDA®QUICK诺如病毒检测(R-Biopharm AG)对肠胃炎患者的粪便样本进行常规筛查,这是一种用于定性检测诺如病毒基因群I和II的快速色谱免疫分析法。随后用分子生物学方法对诺如病毒阳性样本进行分析。粪便混悬液(10%)用磷酸盐缓冲盐水配制,按照厂家说明使用QIAamp病毒RNA试剂盒(Qiagen)提取核酸。为了研究诺如病毒基因组(C区)的基因型分布,采用RT-PCR方法,利用QIAquick PCR纯化试剂盒(Qiagen)和测序(Eurofins Genomics)对PCR产物进行纯化。获得的序列用MEGA X软件进行分析,并用诺如病毒分型工具2.0版(https://www.rivm.nl/mpf/typingtool/ Norovirus /)进行系统发育分析。结果:在研究期间,共鉴定出14种诺如病毒基因型或基因组变体NoV GI、NoV GII和NoV GIX(以前为NoV GII.15)。主要基因型NoV GII.4 Sydney-2012占诺如病毒胃肠炎病例总数的70.3%。在34个月的研究期间,有24个月检测到这种诺如病毒变体。总体而言,诺如病毒感染在秋冬季节(10月至3月)增加,确诊病例68例(57.6%)。虽然所有年龄组(年龄范围0 ~ 96岁,中位8岁,平均27.9岁)均有诺瓦克病毒感染,但统计分析显示0 ~ 4岁年龄组与老年患者的诺瓦克病毒感染发生率差异有统计学意义(χ2 = 3.95,P = 0.047)。许多患者(51例)是皮尔森城区的居民。病例史资料显示,其中35例(29.7%)在发病时有另一位家庭成员出现胃肠炎症状。结论:该初步研究不仅是在皮尔森地区,而且是在整个捷克共和国首次尝试绘制诺如病毒分子流行病学图谱。尽管官方报告的病例数量相对较少,但诺如病毒无疑是该国肠胃炎的最重要原因之一。因此,有必要进行进一步的研究,以扩大其生态和循环的知识体系。
{"title":"Genotyping of noroviruses from patients of the Pilsen University Hospital in the Czech Republic, 2017-2020.","authors":"P Pazdiora,&nbsp;P Vašíčková,&nbsp;M Krzyžánková","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Noroviruses are members of the Caliciviridae family and are currently segregated into at least 10 genogroups. The distribution of these viruses in the Czech Republic has not yet been investigated in detail. A pilot study was performed to contribute to the overall knowledge and understanding of norovirus circulation in the population. Clinical specimens from patients diagnosed with norovirus infection during their hospitalization at the Pilsen University Hospital were genotyped.</p><p><strong>Material and methods: </strong>A total of 118 patients were diagnosed with norovirus infection between July 2017 and March 2020. Stool samples from patients presenting with gastroenteritis were routinely screened by the RIDA®QUICK Norovirus Test (R-Biopharm AG), a rapid chromatographic immunoassay for the qualitative detection of Norovirus genogroups I and II, according to the manufacturers instructions. Norovirus positive samples were subsequently analysed by molecular biological methods. Stool suspensions (10%) were prepared with phosphate-buffered saline, and nucleic acid was extracted using the QIAamp Viral RNA kit (Qiagen) according to the manufacturers instructions. To investigate the genotype distribution, RT-PCR targeting specific sections of the norovirus genome (region C) was employed, followed by purification of PCR products using the QIAquick PCR Purification Kit (Qiagen) and sequencing (Eurofins Genomics). The sequences obtained were analysed by the MEGA X software, and the results of phylogenetic analyses were confirmed by Norovirus Typing Tool Version 2.0 (https://www.rivm.nl/mpf/typingtool/ norovirus/.</p><p><strong>Results: </strong>During the study period, 14 norovirus genotypes or genogroup variants NoV GI, NoV GII and NoV GIX (previously NoV GII.15) were identified. The major genotype NoV GII.4 Sydney-2012 accounted for a total of 70.3% of norovirus gastroenteritis cases. This norovirus variant was detected in 24 months out of 34 months of the study period. In general, the number of norovirus infections increased during autumn and winter months (October to March) when 68 (57.6%) cases were diagnosed. Although norovirus infection was confirmed in all age categories (age range 0-96 years, median 8, mean 27.9), the statistical analysis revealed a significant difference in the incidence of NoV GII.4 infection between the age group 0-4 years and older patients (&#967;2 = 3.95, P = 0.047). Many patients (51) were residents of the Pilsen-city district. The case history data showed that 35 of them (29.7%) had another family member who developed symptoms of gastroenteritis at the time of the onset of their infection.</p><p><strong>Conclusion: </strong>The pilot study is the first attempt to map the molecular epidemiology of noroviruses, not only in the Pilsen Region but also in the whole Czech Republic. Despite the relatively low number of officially reported cases, noroviruses are undoubtedly one of the most importan","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"70 4","pages":"233-240"},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39856555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experience with viral hepatitis C treatment among people who inject drugs and participate in a methadone substitution treatment program. 在注射毒品并参与美沙酮替代治疗方案的人群中进行病毒性丙型肝炎治疗的经验。
IF 0.5 4区 医学 Q4 Medicine Pub Date : 2021-01-01
L Krekulová, L Vavrinčíková

Objectives: Long-term monitoring of the mutual effects of chronic viral hepatitis C (VHC) treatment and tailored addiction treatment. In 2016, the World Health Organization (WHO) published an action plan to eliminate viral hepatitis C globally by 2030. People who inject drugs (PWID) are a key population that needs increased attention and care. Two decades before the announcement of the WHO plan for the global elimination of HCV (hepatitis C virus), the Remedis Medical Facility, where the study was conducted, established a “Comprehensive Care Program for patients with substance use disorders and addictive behaviour”.

Methods: We evaluated all patients who were in the methadone program as of 1 March 2020, regardless of OST duration, OST dosage, age or gender. Their epidemiological and demographic data obtained during a structured clinical interview and laboratory test results were analysed.

Results: Of 24 patients on methadone substitution therapy, 12 (50%) were anti-HCV negative before starting OST. None of them became newly infected with hepatitis C virus (HCV) during OST. The remaining 12 of the study patients were anti-HCV positive. Ten of them have already undergone successful treatment for viral hepatitis. Two patients were re-infected with HCV.

Conclusion: The presented work confirms the high efficacy of chronic VHC treatment among PWID in inducing suitable conditions. We consider combination of HCV infection treatment and targeted tailored addiction treatment as a starting point for achieving control over the HCV epidemic in the Czech Republic, with a possible positive impact on other blood-borne infections related to risky behaviour.

目的:长期监测慢性丙型肝炎(VHC)治疗和定制成瘾治疗的相互作用。2016年,世界卫生组织(世卫组织)发布了一项到2030年在全球消除病毒性丙型肝炎的行动计划。注射吸毒者是需要更多关注和护理的关键人群。在宣布世卫组织全球消除丙型肝炎病毒计划的20年前,开展这项研究的雷米迪斯医疗机构就为有物质使用障碍和成瘾行为的患者制定了一项“综合护理规划”。方法:我们评估了截至2020年3月1日在美沙酮项目中的所有患者,无论OST持续时间、OST剂量、年龄或性别。通过结构化的临床访谈和实验室测试结果分析了他们的流行病学和人口统计数据。结果:在24例接受美沙酮替代治疗的患者中,12例(50%)在开始OST前抗hcv阴性。在OST期间,没有新感染丙型肝炎病毒(HCV)。其余12例研究患者为抗hcv阳性。其中10人已经接受了病毒性肝炎的成功治疗。2例患者再次感染HCV。结论:慢性VHC治疗在PWID患者诱导适宜条件方面具有较高的疗效。我们认为HCV感染治疗和有针对性的成瘾治疗相结合是实现控制捷克共和国HCV流行的起点,可能对其他与危险行为相关的血源性感染产生积极影响。
{"title":"Experience with viral hepatitis C treatment among people who inject drugs and participate in a methadone substitution treatment program.","authors":"L Krekulová,&nbsp;L Vavrinčíková","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>Long-term monitoring of the mutual effects of chronic viral hepatitis C (VHC) treatment and tailored addiction treatment. In 2016, the World Health Organization (WHO) published an action plan to eliminate viral hepatitis C globally by 2030. People who inject drugs (PWID) are a key population that needs increased attention and care. Two decades before the announcement of the WHO plan for the global elimination of HCV (hepatitis C virus), the Remedis Medical Facility, where the study was conducted, established a &#8220;Comprehensive Care Program for patients with substance use disorders and addictive behaviour&#8221;.</p><p><strong>Methods: </strong>We evaluated all patients who were in the methadone program as of 1 March 2020, regardless of OST duration, OST dosage, age or gender. Their epidemiological and demographic data obtained during a structured clinical interview and laboratory test results were analysed.</p><p><strong>Results: </strong>Of 24 patients on methadone substitution therapy, 12 (50%) were anti-HCV negative before starting OST. None of them became newly infected with hepatitis C virus (HCV) during OST. The remaining 12 of the study patients were anti-HCV positive. Ten of them have already undergone successful treatment for viral hepatitis. Two patients were re-infected with HCV.</p><p><strong>Conclusion: </strong>The presented work confirms the high efficacy of chronic VHC treatment among PWID in inducing suitable conditions. We consider combination of HCV infection treatment and targeted tailored addiction treatment as a starting point for achieving control over the HCV epidemic in the Czech Republic, with a possible positive impact on other blood-borne infections related to risky behaviour.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"70 1","pages":"18-25"},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25588848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preventive measures, risk behaviour and the most common health problems in Czech travellers: a prospective questionnaire study in post-travel clinic outpatients. 预防措施、危险行为和捷克旅行者中最常见的健康问题:对旅行后诊所门诊病人的前瞻性问卷调查研究。
IF 0.5 4区 医学 Q4 Medicine Pub Date : 2021-01-01
V Grebenyuk, J Lhoťan, T Rudová, L Richterová, H Roháčová, F Stejskal, M Trojánek

Objective:  The aim of this study was to evaluate attitudes towards the available preventive measures, risk behaviour and health problems in Czech travellers to tropical and subtropical regions.

Materials and methods:  The prospective study included patients of all ages with a history of recent travel to risky countries who presented to the post-travel clinic of the Hospital Na Bulovce in Prague within two months after return, from February 2009 to June 2018. The data were collec-ted through a questionnaire survey and from electronic medical records.

Results:  Nine hundred and thirty-four patients (473 M and 461 F, age median of 32 years, IQR 27-39) participated in the study. The most frequent destinations were South-East Asia (332; 35.5%), South Asia (176, 18.8%), and Sub-Saharan Africa (172; 18.4%). The most common reasons for tra-vel were tourism (772; 82.7%) and business (111; 11.9%). An underlying chronic disease was reported by 317 patients (33.9%). Pre-travel health consultation was sought by 415 travellers (44.4%); however, only 312 (33.4%) of the respondents were properly vaccinated. Preventive malaria chemoprophylaxis was indicated in a total of 151 travellers (16.2%) but was only received by 44/151 patients (29.1%). Risky eating or drinking behaviour was admitted by 832 (89.1%) respondents and low standard accommodation by 525 (56.2 %) travellers. The most commonly reported clinical syndromes were acute and chronic diarrhoea (266; 28.5%), febrile illness (240; 25.7%) and skin lesions (166; 17.8%). A total of 199 patients presented with tropical infection (21.3%) and 63 with a vaccine-preventable infection or malaria (6.7%).  Conclusions: The study shows that the adherence of Czech travellers to preventive measures is relatively low, and along with risky behaviours, has a significant impact on travel-related morbidity. However, vaccine-preventable infections only accounted for a small fraction of travel-related illness, which is in accordance with other epidemiological studies and points out the need for a more comprehensive interdisciplinary approach to pre-travel health consultations.

目的:本研究的目的是评估前往热带和亚热带地区的捷克旅行者对现有预防措施、危险行为和健康问题的态度。材料和方法:前瞻性研究纳入了2009年2月至2018年6月期间在布拉格Na Bulovce医院的旅行后诊所就诊的所有年龄的近期有危险国家旅行史的患者。这些数据是通过问卷调查和电子医疗记录收集的。结果:934例患者(男473例,女461例,年龄中位数32岁,IQR 27-39)参与了研究。最常见的目的地是东南亚(332;35.5%),南亚(176人,18.8%)和撒哈拉以南非洲(172人;18.4%)。最常见的旅行原因是旅游(772;82.7%)和商业(111;11.9%)。317例(33.9%)患者报告有潜在的慢性疾病。415名旅行者(44.4%)寻求旅行前健康咨询;然而,只有312人(33.4%)接种了适当的疫苗。151名旅行者(16.2%)接受了预防性疟疾化学预防,但151名患者中只有44名(29.1%)接受了化学预防。832名(89.1%)受访者承认有危险的饮食行为,525名(56.2%)旅行者承认有低标准的住宿。最常见的临床综合征是急性和慢性腹泻(266;28.5%),发热性疾病(240;25.7%)和皮肤病变(166;17.8%)。共有199名患者表现为热带感染(21.3%),63名患者表现为疫苗可预防感染或疟疾(6.7%)。结论:研究表明,捷克旅行者对预防措施的依从性相对较低,并且伴随着危险行为,对旅行相关发病率有显著影响。然而,疫苗可预防的感染只占与旅行有关的疾病的一小部分,这与其他流行病学研究一致,并指出需要对旅行前的健康咨询采取更全面的跨学科方法。
{"title":"Preventive measures, risk behaviour and the most common health problems in Czech travellers: a prospective questionnaire study in post-travel clinic outpatients.","authors":"V Grebenyuk,&nbsp;J Lhoťan,&nbsp;T Rudová,&nbsp;L Richterová,&nbsp;H Roháčová,&nbsp;F Stejskal,&nbsp;M Trojánek","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong> The aim of this study was to evaluate attitudes towards the available preventive measures, risk behaviour and health problems in Czech travellers to tropical and subtropical regions.</p><p><strong>Materials and methods: </strong> The prospective study included patients of all ages with a history of recent travel to risky countries who presented to the post-travel clinic of the Hospital Na Bulovce in Prague within two months after return, from February 2009 to June 2018. The data were collec-ted through a questionnaire survey and from electronic medical records.</p><p><strong>Results: </strong> Nine hundred and thirty-four patients (473 M and 461 F, age median of 32 years, IQR 27-39) participated in the study. The most frequent destinations were South-East Asia (332; 35.5%), South Asia (176, 18.8%), and Sub-Saharan Africa (172; 18.4%). The most common reasons for tra-vel were tourism (772; 82.7%) and business (111; 11.9%). An underlying chronic disease was reported by 317 patients (33.9%). Pre-travel health consultation was sought by 415 travellers (44.4%); however, only 312 (33.4%) of the respondents were properly vaccinated. Preventive malaria chemoprophylaxis was indicated in a total of 151 travellers (16.2%) but was only received by 44/151 patients (29.1%). Risky eating or drinking behaviour was admitted by 832 (89.1%) respondents and low standard accommodation by 525 (56.2 %) travellers. The most commonly reported clinical syndromes were acute and chronic diarrhoea (266; 28.5%), febrile illness (240; 25.7%) and skin lesions (166; 17.8%). A total of 199 patients presented with tropical infection (21.3%) and 63 with a vaccine-preventable infection or malaria (6.7%).  Conclusions: The study shows that the adherence of Czech travellers to preventive measures is relatively low, and along with risky behaviours, has a significant impact on travel-related morbidity. However, vaccine-preventable infections only accounted for a small fraction of travel-related illness, which is in accordance with other epidemiological studies and points out the need for a more comprehensive interdisciplinary approach to pre-travel health consultations.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"70 1","pages":"32-41"},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25588850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
If a vaccine against COVID-19 was available, would you like to be vaccinated? And are you vaccinated against flu and other diseases? A survey among university students during state of emergency. 如果有COVID-19疫苗,你想接种疫苗吗?你接种过流感和其他疾病的疫苗了吗?紧急状态下大学生的调查。
IF 0.5 4区 医学 Q4 Medicine Pub Date : 2021-01-01
M Sněhota, J Vlčková, K Čížková, E Klásková, H Kolářová, H Kollárová

Aim: Achieving sufficient vaccination rate (and herd immunity respectively) is considered to be the most promising strategy for prevention of outbreaks of novel coronavirus disease in future. The main aim of this work was to compare willingness of university students to receive vaccine against COVID-19 with vaccines for adults against other well-known diseases. Another aim was to assess students´ opinion on growing trend of parents refusing to vaccinate children.

Methods: The online questionnaire shared with students consisted of 12 questions. It was distributed via university bulk emails and social media.

Results: 3,133 students responded to our questionnaire. Overall university response rate was 15.9%. Students of our university showed significantly much stronger interest in receiving vaccine against COVID-19 than vaccine against other diseases (p < 0.0001). Students also showed strong pro-vaccination attitude to vaccination of children.

Conclusion: The study showed very well sudden change of attitude of university students to vaccination of adults at the time of strong restrictive regulations. Most of university students had pro-vaccination attitude to vaccination of children.

目的:实现足够的疫苗接种率(和群体免疫)被认为是未来预防新型冠状病毒病爆发最有希望的策略。这项工作的主要目的是比较大学生接种COVID-19疫苗和成人接种其他已知疾病疫苗的意愿。另一个目的是评估学生对父母拒绝给孩子接种疫苗的趋势的看法。方法:对学生进行在线问卷调查,共12个问题。它是通过大学群发邮件和社交媒体传播的。结果:3133名学生参与了问卷调查。总体大学回应率为15.9%。我校学生对新冠肺炎疫苗接种的兴趣明显高于其他疾病疫苗接种(p <0.0001)。学生对儿童接种疫苗也表现出强烈的支持接种态度。结论:本研究很好地反映了在严格的管制下,大学生对成人疫苗接种态度的突然变化。大多数大学生对儿童接种疫苗持赞成态度。
{"title":"If a vaccine against COVID-19 was available, would you like to be vaccinated? And are you vaccinated against flu and other diseases? A survey among university students during state of emergency.","authors":"M Sněhota,&nbsp;J Vlčková,&nbsp;K Čížková,&nbsp;E Klásková,&nbsp;H Kolářová,&nbsp;H Kollárová","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aim: </strong>Achieving sufficient vaccination rate (and herd immunity respectively) is considered to be the most promising strategy for prevention of outbreaks of novel coronavirus disease in future. The main aim of this work was to compare willingness of university students to receive vaccine against COVID-19 with vaccines for adults against other well-known diseases. Another aim was to assess students´ opinion on growing trend of parents refusing to vaccinate children.</p><p><strong>Methods: </strong>The online questionnaire shared with students consisted of 12 questions. It was distributed via university bulk emails and social media.</p><p><strong>Results: </strong>3,133 students responded to our questionnaire. Overall university response rate was 15.9%. Students of our university showed significantly much stronger interest in receiving vaccine against COVID-19 than vaccine against other diseases (p &lt; 0.0001). Students also showed strong pro-vaccination attitude to vaccination of children.</p><p><strong>Conclusion: </strong>The study showed very well sudden change of attitude of university students to vaccination of adults at the time of strong restrictive regulations. Most of university students had pro-vaccination attitude to vaccination of children.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"70 3","pages":"147-155"},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39514538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 associated Paediatric Inflammatory Multisystem Syndrome (PIMS) in children. 儿童COVID-19相关的儿童炎症多系统综合征(PIMS)
IF 0.5 4区 医学 Q4 Medicine Pub Date : 2021-01-01
J Klučka, M Kratochvíl, P Dominik, L Homola, O Horák, J Nečas, P Jabandžiev, P Štourač

The clinical course of the SARS-CoV-2 virus infection (COVID-19 disease) in paediatric patients is predominantly mild. However, in a small percentage of paediatric patients, the COVID-19 could lead to the development of with the Paediatric Inflammatory Multisystem Syndrome (PIMS) presenting as high fever, gastrointestinal symptoms, neurological symptomatology and even as multiorgan dysfunction. These three cases represent the first published report of critically ill paediatric patients with PIMS in the Czech Republic.

小儿SARS-CoV-2病毒感染(COVID-19病)的临床病程以轻度为主。然而,在一小部分儿科患者中,COVID-19可能导致儿童炎症多系统综合征(PIMS)的发展,表现为高烧、胃肠道症状、神经症状,甚至多器官功能障碍。这三个病例是捷克共和国首次发表的患有PIMS的危重儿科患者报告。
{"title":"COVID-19 associated Paediatric Inflammatory Multisystem Syndrome (PIMS) in children.","authors":"J Klučka,&nbsp;M Kratochvíl,&nbsp;P Dominik,&nbsp;L Homola,&nbsp;O Horák,&nbsp;J Nečas,&nbsp;P Jabandžiev,&nbsp;P Štourač","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The clinical course of the SARS-CoV-2 virus infection (COVID-19 disease) in paediatric patients is predominantly mild. However, in a small percentage of paediatric patients, the COVID-19 could lead to the development of with the Paediatric Inflammatory Multisystem Syndrome (PIMS) presenting as high fever, gastrointestinal symptoms, neurological symptomatology and even as multiorgan dysfunction. These three cases represent the first published report of critically ill paediatric patients with PIMS in the Czech Republic.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"70 4","pages":"281-284"},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39717489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detailed molecular characterization of Neisseria meningitidis isolates by whole genome sequencing (WGS), Czech Republic, 2010-2019. 捷克共和国2010-2019年脑膜炎奈瑟菌全基因组测序(WGS)的详细分子特征
IF 0.5 4区 医学 Q4 Medicine Pub Date : 2021-01-01
M Honskus, Z Okonji, M Musílek, P Křížová

Aim: Presentation of the first results of the analysis of Neisseria meningitidis isolates from invasive meningococcal disease and from clinically and/or epidemiologically linked cases from 2010-2019. Whole genome sequencing (WGS) was used for the study.

Material and methods: The study set included 59 isolates of N. meningitidis from 2010-2019. Serogrouping was done by conventional serological methods and confirmed by RT-PCR. WGS was used for detailed molecular characterization, covering not only basic genes but also ribosomal and capsular genes, antibiotic resistance gene penA, and outer membrane protein gene porA.

Results: WGS analysis of N. meningitidis isolates resulted in a detailed molecular characterization. In a large part of the genes analysed, new mutated allelic variants were found. They were submitted to the PubMLST database and subsequently annotated by the curator. All 59 study isolates were assigned to BAST types, characterized by a unique combination of allelic variants of N. meningitidis B vaccine (MenB vaccine) antigen genes. Overall, 32 different BAST types were identified, and 10 isolates either carried an unknown combination of BAST loci or a new allelic variant in some of the BAST loci. Furthermore, the MenDeVAR index, which provides information on the functional effect of MenB vaccines on a given isolate, was determined.

Conclusions: The results obtained add to the body of knowledge of the transmission of invasive and non-invasive strains of N. meningitidis in the population. The WGS analysis provided detailed data on the coverage of these strains by new MenB vaccines.

目的:介绍2010-2019年侵袭性脑膜炎球菌病和临床和/或流行病学相关病例中分离的脑膜炎奈瑟菌的初步分析结果。采用全基因组测序(WGS)技术进行研究。材料与方法:纳入2010-2019年59株脑膜炎奈瑟菌。采用常规血清学方法进行血清分型,RT-PCR证实。WGS对基本基因、核糖体基因、荚膜基因、耐药基因penA、外膜蛋白基因porA进行了详细的分子表征。结果:WGS分析对脑膜炎奈瑟菌分离株进行了详细的分子表征。在分析的大部分基因中,发现了新的突变等位变异。它们被提交到PubMLST数据库,随后由管理员进行注释。所有59株研究分离株被划分为BAST型,其特征是脑膜炎奈菌B疫苗(MenB疫苗)抗原基因等位变异的独特组合。总共鉴定出32种不同的BAST类型,其中10种分离株携带未知的BAST位点组合或在某些BAST位点上携带新的等位基因变体。此外,还确定了MenDeVAR指数,该指数提供了关于MenB疫苗对特定分离物的功能效果的信息。结论:所得结果增加了对脑膜炎奈瑟菌侵袭性和非侵袭性菌株在人群中的传播的认识。WGS分析提供了新的b型脑膜炎球菌疫苗对这些毒株覆盖的详细数据。
{"title":"Detailed molecular characterization of Neisseria meningitidis isolates by whole genome sequencing (WGS), Czech Republic, 2010-2019.","authors":"M Honskus,&nbsp;Z Okonji,&nbsp;M Musílek,&nbsp;P Křížová","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aim: </strong>Presentation of the first results of the analysis of Neisseria meningitidis isolates from invasive meningococcal disease and from clinically and/or epidemiologically linked cases from 2010-2019. Whole genome sequencing (WGS) was used for the study.</p><p><strong>Material and methods: </strong>The study set included 59 isolates of N. meningitidis from 2010-2019. Serogrouping was done by conventional serological methods and confirmed by RT-PCR. WGS was used for detailed molecular characterization, covering not only basic genes but also ribosomal and capsular genes, antibiotic resistance gene penA, and outer membrane protein gene porA.</p><p><strong>Results: </strong>WGS analysis of N. meningitidis isolates resulted in a detailed molecular characterization. In a large part of the genes analysed, new mutated allelic variants were found. They were submitted to the PubMLST database and subsequently annotated by the curator. All 59 study isolates were assigned to BAST types, characterized by a unique combination of allelic variants of N. meningitidis B vaccine (MenB vaccine) antigen genes. Overall, 32 different BAST types were identified, and 10 isolates either carried an unknown combination of BAST loci or a new allelic variant in some of the BAST loci. Furthermore, the MenDeVAR index, which provides information on the functional effect of MenB vaccines on a given isolate, was determined.</p><p><strong>Conclusions: </strong>The results obtained add to the body of knowledge of the transmission of invasive and non-invasive strains of N. meningitidis in the population. The WGS analysis provided detailed data on the coverage of these strains by new MenB vaccines.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"70 3","pages":"168-177"},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39512001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Epidemiologie Mikrobiologie Imunologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1